Production (Stage)
Cytophage Technologies Ltd.
CYTO.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 507.00K | 1.07M | 1.75M | 2.68M | 4.12M |
| Total Receivables | 68.90K | 142.00K | 298.60K | 279.40K | 292.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.90K | 19.90K | 6.30K | 4.80K | 10.60K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 55.80K | 39.60K | 63.50K | 87.30K | 188.70K |
| Total Current Assets | 639.50K | 1.27M | 2.12M | 3.05M | 4.61M |
|
|
|||||
| Total Current Assets | 639.50K | 1.27M | 2.12M | 3.05M | 4.61M |
| Net Property, Plant & Equipment | 1.99M | 2.16M | 2.43M | 2.29M | 1.84M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 2.63M | 3.43M | 4.54M | 5.34M | 6.46M |
|
|
|||||
| Total Accounts Payable | 218.20K | 145.20K | 154.00K | 175.30K | 197.90K |
| Total Accrued Expenses | 145.70K | 180.50K | 124.40K | 125.30K | 191.20K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 155.50K | 149.40K | 220.90K | 218.10K | 239.60K |
| Total Finance Division Other Current Liabilities | 0.00 | -- | -- | -- | -- |
| Total Other Current Liabilities | 0.00 | -- | -- | -- | -- |
| Total Current Liabilities | 519.40K | 475.10K | 499.30K | 518.70K | 628.70K |
|
|
|||||
| Total Current Liabilities | 519.40K | 475.10K | 499.30K | 518.70K | 628.70K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 879.00K | 919.60K | 955.00K | 979.00K | 1.03M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00 | -- | -- | -- | -- |
| Total Liabilities | 1.40M | 1.39M | 1.45M | 1.50M | 1.65M |
|
|
|||||
| Common Stock & APIC | 17.59M | 17.57M | 18.71M | 18.40M | 18.58M |
| Retained Earnings | -19.29M | -18.46M | -19.03M | -17.99M | -17.26M |
| Treasury Stock & Other | 2.93M | 2.93M | 3.41M | 3.44M | 3.48M |
| Total Common Equity | 1.23M | 2.04M | 3.09M | 3.85M | 4.80M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.23M | 2.04M | 3.09M | 3.85M | 4.80M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.23M | 2.04M | 3.09M | 3.85M | 4.80M |
|
|
|||||